442 results on '"Fanaroff, Alexander C."'
Search Results
2. Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
3. Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study
4. Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality
5. Abstract 17514: Changing Default Prescription Length to Reduce Barriers to Statin Adherence
6. Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia
7. A randomized controlled trial of gamification, financial incentives, or both to increase physical activity among patients with elevated risk for cardiovascular disease: rationale and design of the be active study
8. Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial
9. Patient Management with Stable Ischemic Heart Disease
10. Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry
11. Independence of clinical events committees: A consensus statement from clinical research organizations
12. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
13. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
14. Chronic Coronary Disease
15. Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem
16. Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
17. Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort.
18. Clinical outcomes and need for intensive care after non-ST-segment-elevation myocardial infarction
19. Radial Access for Peripheral Interventions
20. Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
21. Standing up for equitable treatment of coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries
22. High-Sensitivity Troponin in Patients With Cancer
23. Economic Considerations in Access to Transcatheter Aortic Valve Replacement
24. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris
25. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion
26. Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed
27. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
28. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials
29. OR6-5 | Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction among United States Hospitals
30. Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry
31. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures
32. Abstract 13567: Variability in Reported Post-percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State
33. Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis
34. Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
35. Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington State
36. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial
37. Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion
38. Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies
39. COVID-19 Thrombotic Complications and Therapeutic Strategies
40. Antiplatelet Therapy in Percutaneous Coronary Intervention
41. Physiologic Assessment of Stent Deployment: SEARCHing for Answers With Post-Percutaneous Coronary Intervention Fractional Flow Reserve
42. Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
43. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention: Report From the NCDR CathPCI Registry
44. Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes
45. Fluoroscopic Guidance for Femoral Artery Access—Pushing Patients Out of the Plane Without a Parachute?
46. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
47. A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges: Summary of Findings From the Cardiac Safety Research Consortium/Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine
48. Focusing on the Future of Cardiovascular Outcomes Research: Highlights From the American Heart Association/American Stroke Association Quality of Care and Outcomes Research 2018 Scientific Sessions
49. Abstract 16543: The Atherosclerosis Candidate Gene Product Kalirin Reduces Atherosclerosis via Macrophage-Specific Mechanisms
50. Abstract 15864: ICU Utilization in Stable ST-segment Elevation Myocardial Infarction Patients Treated With Rapid Reperfusion: A Report From ACTION Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.